Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2019
Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
Christer Nilsson, Erik Hulegårdh, Hege Garelius, et al.
Leukemia & Lymphoma
|
August 3, 2018
Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML
Erik Delsing Malmberg, Sofie Johansson Alm, Malin Nicklasson, et al.
Genes, Chromosomes & Cancer
|
August 31, 2004
MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q)
Therese Nilsson, Lars Nilsson, Stig Lenhoff, et al.
Haematologica
|
March 9, 2004
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma
Therese Standal, Henrik Hjorth-Hansen, Thomas Rasmussen, et al.
Leukemia Research Reports
|
December 31, 2015
Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation
Anna Lübking, Sebastian Vosberg, Nikola P Konstandin, et al.
Journal of Clinical Apheresis
|
August 24, 2017
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
Simon Pahnke, Gunnar Larfors, Ulla Axdorph-Nygell, et al.
Haematologica
|
March 7, 2024
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Sabine Blum, Yves Chalandon, Myriam Labopin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 21, 2014
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Joachim Burman, Ellen Iacobaeus, Anders Svenningsson, et al.
American Journal of Hematology
|
October 4, 2017
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
Vladimir Lj Lazarevic, Myriam Labopin, Wu Depei, et al.
Cancer
|
October 13, 2005
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation
Jacopo Peccatori, Lisbeth Barkholt, Tanner Demirer, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2019
Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
Christer Nilsson, Erik Hulegårdh, Hege Garelius, et al.
Leukemia & Lymphoma
|
August 3, 2018
Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML
Erik Delsing Malmberg, Sofie Johansson Alm, Malin Nicklasson, et al.
Genes, Chromosomes & Cancer
|
August 31, 2004
MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q)
Therese Nilsson, Lars Nilsson, Stig Lenhoff, et al.
Haematologica
|
March 9, 2004
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma
Therese Standal, Henrik Hjorth-Hansen, Thomas Rasmussen, et al.
Leukemia Research Reports
|
December 31, 2015
Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation
Anna Lübking, Sebastian Vosberg, Nikola P Konstandin, et al.
Journal of Clinical Apheresis
|
August 24, 2017
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
Simon Pahnke, Gunnar Larfors, Ulla Axdorph-Nygell, et al.
Haematologica
|
March 7, 2024
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Sabine Blum, Yves Chalandon, Myriam Labopin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 21, 2014
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Joachim Burman, Ellen Iacobaeus, Anders Svenningsson, et al.
American Journal of Hematology
|
October 4, 2017
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
Vladimir Lj Lazarevic, Myriam Labopin, Wu Depei, et al.
Cancer
|
October 13, 2005
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation
Jacopo Peccatori, Lisbeth Barkholt, Tanner Demirer, et al.
Page
of 8